China drug firm eyes $2.2 bln Hong Kong IPO Hong Kong (AFP) May 3, 2011 Shanghai Pharmaceuticals, one of China's biggest drugmakers, plans to raise as much as $2.2 billion in an initial public offering ahead of its market listing in Hong Kong this month. The company will sell 664 million shares in a price range of HK$21.80-HK$26.00 ($2.81-$3.35) per share ahead of its May 20 listing, Dow Jones Newswires reported, citing unnamed people familiar with the situation. The drugmaker has confirmed four so-called cornerstone investors -- including Singapore's state investment firm Temasek and pharmaceutical giant Pfizer -- to buy a total of $550 million worth of its shares. Hong Kong-based investment firm Guoco Group and Bank of China Investment are the other two cornerstone investors, Dow Jones said. Since last year, the Chinese drug firm has acquired, or signed agreements to acquire, at least nine companies to boost its drug distribution business in the country's fragmented pharmaceutical sector, state press has reported.
Share This Article With Planet Earth
Related Links Global Trade News
Buffett to shareholders: deputy's action 'inexcusable' Omaha, Nebraska (AFP) April 30, 2011 Billionaire investor Warren Buffett sought to draw a line Saturday under a controversy sullying his normally Teflon image, blasting a key lieutenant's behavior as "inexplicable and inexcusable." The revered magnate, who 20 years ago vowed to ruthlessly deal with staff who tarnish his firm's reputation, told a stadium full of attentive shareholders that David Sokol had broken company rules i ... read more |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |